Novacyt Statistics
Total Valuation
Novacyt has a market cap or net worth of GBP 49.90 million. The enterprise value is 20.33 million.
Market Cap | 49.90M |
Enterprise Value | 20.33M |
Important Dates
The next estimated earnings date is Thursday, September 26, 2024.
Earnings Date | Sep 26, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 68.43M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 4.23 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.72 |
EV / Sales | 1.80 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -0.80 |
Financial Position
The company has a current ratio of 2.92, with a Debt / Equity ratio of 15.71.
Current Ratio | 2.92 |
Quick Ratio | 2.73 |
Debt / Equity | 15.71 |
Debt / EBITDA | n/a |
Debt / FCF | -0.54 |
Interest Coverage | -11.99 |
Financial Efficiency
Return on equity (ROE) is -27.46% and return on invested capital (ROIC) is -17.00%.
Return on Equity (ROE) | -27.46% |
Return on Assets (ROA) | -13.43% |
Return on Capital (ROIC) | -17.00% |
Revenue Per Employee | 48,857 |
Profits Per Employee | -119,376 |
Employee Count | 237 |
Asset Turnover | 0.08 |
Inventory Turnover | 2.60 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.37% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -9.37% |
50-Day Moving Average | 62.85 |
200-Day Moving Average | 57.18 |
Relative Strength Index (RSI) | 47.54 |
Average Volume (20 Days) | 1,812,979 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novacyt had revenue of GBP 11.58 million and -28.29 million in losses. Loss per share was -0.40.
Revenue | 11.58M |
Gross Profit | 3.73M |
Operating Income | -29.52M |
Pretax Income | -28.57M |
Net Income | -28.29M |
EBITDA | -19.87M |
EBIT | -29.52M |
Loss Per Share | -0.40 |
Balance Sheet
The company has 44.06 million in cash and 13.70 million in debt, giving a net cash position of 30.36 million.
Cash & Cash Equivalents | 44.06M |
Total Debt | 13.70M |
Net Cash | 30.36M |
Net Cash Per Share | n/a |
Equity (Book Value) | 87.24M |
Book Value Per Share | 1.24 |
Working Capital | 56.88M |
Cash Flow
In the last 12 months, operating cash flow was -24.99 million and capital expenditures -517,000, giving a free cash flow of -25.51 million.
Operating Cash Flow | -24.99M |
Capital Expenditures | -517,000 |
Free Cash Flow | -25.51M |
FCF Per Share | n/a |
Margins
Gross margin is 32.21%, with operating and profit margins of -254.91% and -244.34%.
Gross Margin | 32.21% |
Operating Margin | -254.91% |
Pretax Margin | -246.72% |
Profit Margin | -244.34% |
EBITDA Margin | -171.63% |
EBIT Margin | -254.91% |
FCF Margin | -220.30% |
Dividends & Yields
Novacyt does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -57.72% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |